The prognosis for lung cancer is the disease's expected course, which helps one understand how their cancer is likely to progress and what treatment options are available to them.
Overall survival rates can vary greatly depending on the cancer type, stage at diagnosis, general health, and how well the treatment works. Some patients with early-stage lung cancer may receive treatment that aims to cure the cancer, whilst others may need long-term treatment to control the cancer.
Whilst survival rates can provide useful information, it is impossible to know exactly how long someone will live. There are now many advances in treating cancer.
Prognosis for lung cancer is an estimate given by medical professionals based on what is known about the cancer and the patient. Physicians will consider several parameters, including the size of the cancer, whether it has progressed to lymph nodes, if it has moved to other parts of the body, the type of cancer, and the results of molecular testing.
Early diagnosis can help improve treatment success as the cancer may still be present in the lung. If the cancer has spread to other parts of the body, treatment will aim to control the cancer.
However, prognosis isn’t solely based on cancer staging. Some late-stage cancers respond well to targeted treatment and immunotherapy, helping patients live longer than previously thought.
Relative five-year survival rate refers to the likelihood that the individual will live five years beyond the diagnosis with a particular form of cancer, compared with the overall population.
Based on data from the US National Cancer Institute (SEER) for diagnoses between 2016-2022, lung & bronchus cancer had an overall five-year relative survival rate of around 29.5%.
Cancer extent — Five-year relative survival rate
[Note: The survival rates shown are based on SEER summary stages and not the actual exact stages (I, II, III and IV). The rates include large numbers of patients in the USA and may not reflect the survival rates in all countries or for individual patients.]
Lung cancer is one of the two categories of cancers, which includes non-small cell lung cancer and small cell lung cancer. These cancers differ in growth and reaction to treatment.
Lung cancer can be broadly categorized as non-small cell lung cancer, which consists of squamous cell carcinoma, adenocarcinoma, and other rare types of lung cancers.
Based on data from the USA, the American Cancer Society reports the following survival rates for non-small cell lung cancer:
This highlights why early detection is so important. However, each patient will be different depending on tumor characteristics, treatment, and general health.
Small cell lung cancer is rare and often grows and spreads more quickly. Treatment will often involve chemotherapy and immunotherapy. Radiotherapy will also be used where appropriate.
The following are the survival rates for small cell lung cancer, according to statistics from the American Cancer Society:
Note: The data may not accurately reflect the effects of more recent treatments because it is based on diagnoses made between 2012 and 2018.
Data from the American Cancer Society for both cancer types.
Many factors can affect how lung cancer develops and how well someone may respond to treatment.
Sometimes lung cancer can be cured. This will often depend on how early it is diagnosed and if it can be fully removed or treated with radiotherapy.
One of the treatment methods for non-small cell lung cancer that is diagnosed at an early stage is surgery. Depending on the circumstances, targeted therapy, immunotherapy, or chemotherapy may also be employed.
Some locally advanced patients can also receive treatment with the intention to cure. Metastatic lung cancer is less likely to be fully cured; however, treatment may control it for a long period of time.
Whether lung cancer can be cured will depend on the cancer type, stage, tumor characteristics, and how well it responds to treatment. You should discuss realistic treatment aims with your oncology team.
Whilst you can’t control everything that affects prognosis, there are several things you can do to help you cope with treatment.
Always speak to your medical team before making any big changes to your diet, exercise, supplements or medication.
Lung cancer prognosis and survival rates depend on many factors such as cancer stage, type, molecular characteristics, general health and how well it responds to treatment. Survival rates tend to be better if cancer is caught early rather than when it has spread. However, you can’t be sure how long someone will live.
There are many treatments available to treat lung cancer depending on your condition: targeted therapy, immunotherapy, chemotherapy, surgery and radiotherapy. Seeing a specialist, understanding your diagnosis and discussing treatment can help you make informed decisions.
Each patient's experience will be different, and the best estimate of prognosis is to discuss your individual test results and treatment options with your oncologist.
Call us at +91-9076972161
Email at care@tenderpalm.com
Welcome to Tender Palm Hospital. Share your enquiry and connect with our team on WhatsApp.